Kuemmel S, Fasching PA, Schmid P, Harbeck N, et al. Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study. Ann Surg Oncol 2026 Feb 25. doi: 10.1245/s10434-026-19121.
PMID: 41739398